NO | Iimveliso | I-HAY | Isicelo | Isalathiso seXabiso eliPhambili | ||||
Ubunyulu | Isomer | Ukungalungisi | * UMax1 | Ukufuma | ||||
1 | I-FMOC-CYS (i-ACM) -oh | I-86060-81-3 | Ukulahlekisa | ≥99.0% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
2 | I-FMOC-CYS (MMT) -OOh | 177582-21-7 | Ukulahlekisa | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
3 | I-FMOC-CYS (i-4-Allylbylbylbylblite) -oh | / | Ukulahlekisa | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
4 | I-MPA (TRT) -OOH | 27144-18-9 | Ukuphela kokulandelelana | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
5 | I-FMOC-TAR (TBU) -O | Ngo-189337-28-8-8 | I-octretide | ≥97.0% | ≤0.3% | ≤0.5% | ≤1.0% | ≤1.0% |
6 | I-FMOC-D-ARG (PBF) -oh | Ngo-187618-60-60-60-6 | Desmopressin | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤2.0% |
7 | I-Fmoc-gly-gly-oh | 35665-38-4 | I-Bintaliridin | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
8 | I-Fmoc-gly-gly-gly-oh | I-170941-79-4 | I-Terlippressin | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
9 | I-Fmoc-gly-gly-gly-gly-oh | / | I-Bintaliridin | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
10 | I-Fmoc-Gly-Asp (TBU) -oh | / | I-Bintaliridin | ≥99.5% | / | ≤0.15% | ≤0.2% | ≤1.0% |
11 | I-BOC-cYS (i-TRT) -OOH | 21947-988-8 | Ukuphela kokulandelelana | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
12 | I-BOC-ARG (PBF) -oh | 200124-22-7 | Ukuphela kokulandelelana | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
13 | Boc-am-oh | I-15761-38-3 | Ukuphela kokulandelelana | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
14 | I-Boc-D-PHE-OH | Ngo-18942-49-9-9-9-9 | Ukuphela kokulandelelana | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
15 | I-boc-gly-oh | 4530-20-5 | Ukuphela kokulandelelana | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
16 | I-BOC-lys (BoC) -oh.dcha | I-15098-69-8 | Ukuphela kokulandelelana | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
17 | I-Boc-SUR (TBU) -UOh -oh | 7738-9-9 | Ukuphela kokulandelelana | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
18 | I-BOC-tur (tbu) -oh | 13734-40-2 | Ukuphela kokulandelelana | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
19 | I-Boc-D-ALA-OH | 7764-95-6 | Ukuphela kokulandelelana | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
20 | I-Boc-intlanganiso | 2488-15-5 | Ukuphela kokulandelelana | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
21 | I-BOC-Tyr (TBU) -oh | I-47375-34-8 | Ukuphela kokulandelelana | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
22 | I-BOC-D-ARG (PDF) -oh | Ngo-187618-60-60-60-6 | Ukuphela kokulandelelana | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
23 | I-Boc-Asp (OTBU) -OH.DCHA | Ngo-1913/4 | Ukuphela kokulandelelana | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
24 | I-Fmoc-homoarg (PBF) -oh | I-1159680-21-3 | Eptifibatide | ≥98.5% | ≤0.2% | / | ≤0.5% | ≤2.0% |
25 | I-FMOC-ASP-OTBUB | 129460-09-9 | I-hidmalfasin | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
26 | I-Fmoc-tyr (mna) -oh | 77128-72-72-4 | ICarbetocin | ≥98.5% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
27 | I-Fmoc-Orn (BoC) -oh | I-109425-55-5-0 | Atosiban I-omnippresin Daptomycin | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤2.0% |
28 | I-Fmoc-D-tyr (et)----oh | 162502-65-0 | Atosiban | ≥99.5% | ≤0.1% | ≤0.1% | ≤0.2% | ≤1.0% |
29 | I-FMOC-ASP (i-owell) -oh | 146982-24-33 | Melatan | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
30 | I-AC-NLE-OH | I-15891-49-3 | Melatan | ≥99.0% | / | ≤0.3% | ≤0.3% | ≤1.0% |
31 | I-FMOC-NLE-OH | 77284-322 | Melatan Amelatide | ≥99.0% | / | ≤0.3% | ≤0.3% | ≤1.0% |
32 | I-AC-glu (otbu) -oh | I-84192-88-1 | I-Argireline I-Acetyl OctapePide-3 | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
33 | I-AC--Ala-Ohuntcha | / | I-Acetyl TetrapePide-5 | ≥99.0% | / | ≤0.3% | ≤0.3% | ≤1.0% |
34 | I-FMOC-ß-ala-oh | 35737-10-1 | I-Acetyl TetrapePide-5 | ≥99.5% | / | ≤0.1% | ≤0.2% | ≤1.0% |
35 | I-Fmoc-hyp (tbu) -oh | 122996-8-8-8-8-8-8-8-8-8 | I-icotibent | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
36 | I-Fmoc-hi-oh | 130309-35-23-25-2 | I-icotibent | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
37 | I-FMOC-D-Tic-oh | 130309-3-0-0 | I-icotibent | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
38 | I-Fmoc-oic-oh | 130309-37-4 | I-icotibent | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
39 | Boc-sar-oh | 13734-36-6 | Saralasin | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
40 | I-FMOC-SAR-oh | 77128-70-2 | Saralasin | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
41 | I-FMOC-tyr (i-S3NA) -h2o | I-106864-37-3 | Isono | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
42 | I-Fmoc-D-Asp (OTB) -oh | I-112883-39-39-3 | Daptomycin | ≥98.5% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
43 | I-AC-Ser (i-TBU) -oh | 77285-09-7 | Amelatide | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
44 | I-Boc-homocys (TRT) -OOH | Ngo-20141-16-16-1 | Duyela | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
45 | I-FMOC-homocys (TRT) -OOH | 167015-23-8 | Duyela | ≥98.0% | ≤0.2% | ≤0.3% | ≤0.5% | ≤1.0% |
46 | I-Fmoc-Dab-oh | 161420-87-7 | I-venom yenyoka | ≥99.0% | ≤0.2% | ≤0.3% | ≤0.3% | ≤1.0% |
* UMax1 = i-max icocekile engaziwayo
Olunye uphawu:
-I-acetic acid: ≤0.02% (zonke iimveliso)
- I-Ethyl Acetate: ≤0.5% (Zonke iimveliso)
-Utywala: ≤0.5% (zonke iimveliso)
-I-Max Ukunqaba inqaba: I-FMOC-TRP) -Uh (143824%) ≤0.3%; Abanye ≤0.2%